ExpreS2ion Biotech
Erbjudandet gäller nya kunder och omfattar handel via Nordnets app eller hemsida i nordiska aktier, ETF:er, teckningsrätter och teckningsoptioner. För fullständiga villkor se nordnet.se/jubileum. Kom ihåg att investeringar alltid innebär en risk.
BioStock: Multiple near-term milestones for ExpreS2ion Biotech
Read the full article at biostock.se:
https://www.biostock.se/2023/03/multiple-near-term-milestones-for-expres2ion-biotech/
This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se
The invitation to persons concerned to subscribe for units in ExpreS2ion Biotechnologies will only take place through the prospectus published on 27 March 2023. The prospectus has been approved and registered by the Financial Supervisory Authority and published on https://expres2ionbio.com/.
| Datum | 2023-03-31, kl 08:45 |
| Källa | Cision |